. Author manuscript; available in PMC: 2019 Jun 1.

Published in final edited form as: J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):169–174. doi: 10.1097/QAI.0000000000001654

TABLE 1.

Characteristics of iPrEx^* and iPrEx-OLE^† Participants in the Urine Biomarker Substudy

	iPrEx (N = 200)			iPrEx-OLE (N = 109)
	Active Arm (N = 100)	Placebo (N = 100)	P	iPrEx-OLE (N = 109)
Age (y)	23 (20, 26)	22 (20, 26)	0.65	30 (24, 43)
Transgender	17 (17%)	18 (18%)	0.85	6 (6%)
Race
Black	12 (12%)	9 (9%)	0.79	11 (10%)
White	14 (14%)	11 (11%)		29 (27%)
Mixed/other	48 (48%)	53 (53%)		55 (50%)
Asian	26 (26%)	27 (27%)		14 (13%)
Ethnicity
Non-Latino	48 (48%)	44 (44%)	0.57	60 (55%)
Latino	52 (52%)	56 (56%)		49 (45%)
Body mass index (kg/m²)	23 (20, 26)	23 (20, 26)	0.74	26 (23, 30)
Systolic blood pressure (mm Hg)	110 (100, 121)	116 (108, 125)	0.99	118 (110, 128)
Diastolic blood pressure (mm Hg)	70 (63, 80)	70 (69, 79)	0.53	76 (70, 81)
Serum creatinine (mg/dL)	0.9 (0.8, 0.9)	0.9 (0.8, 0.9)	0.40	0.9 (0.8, 0.9)
eGFR (ml/min/1.73m²)	124 (116, 130)	124 (117, 132)	0.85	114 (100, 123)

Continuous data are summarized as median (interquartile range).

Characteristics at time of urine collection in iPrEx participants.

^†

Characteristics at baseline for OLE participants.